Inhibition of Proliferation and Modulation of Estradiol Metabolism: Novel Mechanisms for Breast Cancer Prevention by the Phytochemical Indole-3-Carbinol

Experimental Biology and Medicine

Volumn 216, Issue 2, 1997, Pages 246-252

  Telang, Nitin T ^a   Katdare, Meena ^a   Bradlow, H Leon ^a   Osborne, Michael P ^a   Fishman, Jack ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; CARCINOGEN; ESTRADIOL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; ESTROGEN METABOLISM; FEMALE; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; REGULATORY MECHANISM;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BENZO(A)PYRENE; BREAST; BREAST NEOPLASMS; CARCINOGENS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; ESTRADIOL; FEMALE; GLUCOSINOLATES; HUMANS; INDOLES; TUMOR CELLS, CULTURED;

EID: 0030881402     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44174     Document Type: Article

References (51)

1. Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinoma: A review and tribute to Charles Brenton Huggins. Cancer Res 45:3415-3443, 1985.
2. Abraham S. Carcinogenesis and Dietary Fat. Boston: Kluwer Academic Publishers, 1989.
3. Sporn MB, Newton DL. Chemoprevention of Cancer with retinoids. Fed Proc 38:2528-2534, 1979.
4. Ip C, Medina D. Current concepts of selenium and mammary tumorigenesis. In: Medina D, Kidwell W, Heppner G, Andersen E, Eds. Cellular and Molecular Biology of Mammary Cancer. New York: Plenum Press, pp479-494, 1987.
5. Steinmetz KA, Potter JD. Vegetables, fruit and cancer. I. Epidemiology. Cancer Causes Control 2:325-357, 1991.
6. Telang NT, Bradlow HL, Osborne MP. Molecular and endocrine biomarkers in noninvolved breast: Relevance to cancer chemoprevention. J Cell Biochem 16G:161-169, 1992.
7. Telang NT, Narayanan R, Bradlow HL, Osbome MP. Coordinated expression of intermediate biomarkers for tumorigenic transformation in Ras transfected mouse mammary epithelial cells. Breast Cancer Res Treat 18:155-163, 1991.
8. Telang NT, Osborne MP, Sweterlitsch L, Narayanan R. Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression. Cell Regulation 1:863-872, 1990.
9. Telang NT, Banerjee MR, Iyer AP, Kundu AB. Neoplastic transformation of epithelial cells in whole mammary gland in vitro. Proc Natl Acad Sci USA. 76:5886-5890, 1979.
10. Suto A, Bradlow HL, Wong, GYC, Osborne MP, Telang NT. Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res Treat 27:193-202, 1993.
11. Telang NT, Katdare M, Bradlow HL, Osborne MP. Estradiol metabolism: An endocrine biomarker for modulation of human mammary carcinogenesis. Environ Health Perspect 105(Suppl. 3):559-564, 1997.
12. Katdare M, Singhal H, Newmark H, Osborne MP, Telang NT. Prevention of mammary preneoplaslic transformation by naturally-occurring tumor inhibitors. Cancer Lett 111:141-147, 1997.
13. Verhoeven DTH, Goldbohm RA, Poppel GV, Vertagen H, Van den Brandt PA. Epidemiological studies on Brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 5:733-748, 1996.
14. Kail MA, Vang O, Clausen J. Effects of dietary broccoli on human in vivo drug metabolizing enzymes: Evaluation of caffeine, oestrone and chlorzoxazone metabolism. Carcinogenesis 17:793-799, 1996.
15. Conney AH, Pantuck EJ, Kuntzmari R, Kappas A, Anderson KE, Alvares AP. Nutrition and chemical biotransformation in mam. Clin Pharmacol Ther 22:707-720, 1977.
16. Subbaramaiah K, Telang NT, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56:4424-4429, 1996.
17. Suto A, Bradlow HL, Wong GYC, Osborne MP, Telang NT. Persistent estrogen responsiveness of Ras oncogene transformed mouse mammary epithelial cells. Steroids 57:262-268, 1992.
18. Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571-1574, 1991.
19. Grubbs C, Steele VE, Caseblol T, Juliana MM, Eto I, Whitaker LM, Dragnev KH, Kellof GJ, Lubet RL. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15:709-716, 1995.
20. IARC Monograph on the Evaluation of Carcinogenic Risk of Chemicals to Man: Polycyclic Aromatic Hydrocarbons. Lyon, France: IARC, Vol 3:p137, 1973.
21. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE. Studies on HER-2/neu Oncogene in human breast and ovarian cancer. Science 244:707-712, 1989.
22. Stampfer MR, Bartley JC. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc Natl Acad Sci USA 82:2394-2398, 1985.
23. Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW. Increased expression of specific tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 53:2272-2278, 1993.
24. Jiang SY, Jordan VC. Growth regulation of estrogen receptor negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 84:580-591, 1992.
25. Goldberg Y, Nassiff II, Pittas A, Tsai LL, Dynlacht BD, Rigas B, Shiff SJ. The antiproliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle regulatory proteins. Oncogene 12:893-901, 1996.
26. Telang NT. Oncogene, estradiol biotransformation and mammary carcinogenesis. Ann NY Acad Sci 784:277-287, 1996.
27. Fishman J, Osborne MP, Telang NT. The role of estrogens in mammary carcinogenesis. Ann NY Acad Sci 768:91-100, 1995.
28. Cotter TG, Lenon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumor and normal cells. Anticancer Res 10:1153-1159, 1990.
29. Stewart BW. Mechanism(s) of apoptosis: Integration of genetic, biochemical and cellular indicators. J Natl Cancer Inst 86:1286-1296, 1994.
30. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 57:237-257, 1993.
31. Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats and humans: A unifying hypothesis. Proc Natl Acad Sci USA 92:3650-3657, 1995.
32. 1 breast cancer. Clin Cancer Res 2:1887-1894, 1996.
33. Osborne MP, Bradlow HL, Wong GYC, Telang NT. Upregulation of estradiol C16α-hydroxylation in human breast tissue: a potential biomarker for breast cancer risk. J Natl Cancer Inst 85:1917-1920, 1993.
34. Liehr JG, Ricci MJ. 4-Hydroxylation of estrogens as markers for human mammary tumors. Proc Natl Acad Sci USA 93:3294-3296, 1996.
35. Lottering ML, Haag M, Seegers JC. Effects of 17β-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 52:5926-5932, 1992.
36. Bradfield CA, Bjeldanes LF. Structure-activity relationship of dietary indoles: A proposed mechanism of action as modifiers of xenobiotic metabolism. J Toxicol Environ Health 21:311-323, 1987.
37. Zhang Y, Talalay P, Cho CG, Posner GH. A major inducer of anti-carcinogenic protective enzymes found in broccoli: Isolation and elucidation of structure. Proc Natl Acad Sci USA 89:2399-2409, 1992.
38. Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52:2085S-2091S, 1992.
39. Mehta RG, Liu J, Constantinou A, Hawthorne M, Pezzuto JM, Moon RC, Moriarty RM. Structure-activity relationships of brassinin in preventing the development of carcinogen-induced mammary lesions in organ culture. Anticancer Res 14:1209-1214, 1994.
40. Mehta RG, Liu J, Constantinou A, Thomas CF, Hawthorne M, You M, Gerhausser C, Pezzuto JM, Moon RC, Moriarty RM. Cancer preventive activity of Brassinin, a phytoalexin from cabbage. Carcinogenesis 16:399-404, 1995.
41. Michnovicz JJ, Bradlow HL. Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 82:947-949, 1990.
42. Bradlow HL, Michnovicz JJ, Halper M, Miller DG, Wong GYC, Osborne MP. Long-term responses of women to indole-3-carbinol or a high-fiber diet. Cancer Epidemiol Biomarkers Prev 3:591-595, 1994.
43. Harris CC. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88:1442-1455, 1996.
44. Hockenbery DM, Nancy G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is a inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990.
45. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Lieberman DA. Tumor suppressor p53 is a regulator of Bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805, 1994.
46. Leek RD, Kaklaminis L, Pezzella F, Gatter KC. Harris AL. Bcl-2 in normal human breast and carcinoma: Association with estrogen receptor positive, epidermal growth factor receptor negative tumors and in situ cancer. Br J Cancer 69:135-139, 1994.
47. Silverstini R, Veroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, DiFronzo M, Rilke F, Veronesi U. The Bcl-2 protein, a prognostic indicator strongly related to p53 protein in lymph node negative breast cancer patients. J Natl Cancer Inst 86:499-504, 1994.
48. Telang NT, Katdare M, Osborne MP. Negative growth regulation of HER-2/neu oncogene-transformed human mammary epithelial cells by a green tea polyphenol. Breast Cancer Res Treat 41:264(Abstract 318), 1996.
49. Kellof GJ, Malone WF, Boone CW, Sigman CC, Fay JR. Progress in applied chemoprevention research. Semin Oncol 17:438-455, 1990.
50. Kellof GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Doody LA, Grenwald P. Development of breast cancer chemopreventive drugs. J Cell Biochem 17G:2-13, 1993.
51. Greenwald P. Preventive clinical trials: An overview. Ann NY Acad Sci 768:129-140, 1995.